Search Results 771-780 of 18483 for Prednisone

  1. Canker sore - Diagnosis and treatment - Mayo Clinic

    If you have several canker sores, your doctor may prescribe a mouth rinse containing the steroid dexamethasone (dek-suh-METH-uh-sown) to reduce pain and ...

  2. Dermatitis - Diagnosis and treatment - Mayo Clinic

    Learn about the symptoms, causes and treatments of this itchy skin condition that affects children and adults, and about how moisturizers help prevent it.

  3. A Study to Perform Synovial Biopsies on Patients with Rheumatoid Arthritis - Mayo Clinic

    Prednisone or equivalent > 10 mg daily; Exclusion criteria are the same for controls. Participating Mayo Clinic locations. Study statuses change often. Please ...

  4. Health Topics - Mayo Clinic News Network

    Bats play an important role in many ecosystems around the world. They are a major predator of night-flying insects, including pests that cost farmers ...

  5. Assessing Benefits And Harms Of Cannabis/Cannabinoid Use Among Cancer Patients Treated In Community Oncology Clinics

    * Participants with chronic or ongoing steroid or immunomodulatory agents (i.e., prednisone, dexamethasone, etanercept, infliximab, etc.). The use of ...

  7. A Study of LY2784544 for Patients with Myeloproliferative Disorders - Mayo Clinic

    Immunosuppressive therapy (for example, corticosteroids greater than 10 mg/day prednisone or equivalent); Radiotherapy; Erythropoietin, thrombopoietin, or ...

  8. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma - Mayo Clinic

    of GEN3017. 8. Receiving immunosuppressive drugs or systemic corticosteroids such as prednisone at doses > 25 milligrams (mg) daily or its equivalent within ...

  9. A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer - Mayo Clinic

    Subjects with a condition requiring systemic treatment with either corticosteroids (>10 mg daily prednisone equivalents) or other immunosuppressive medications ...

  10. A Study to Evaluate Effectiveness and Safety of MBG453 in Combination with Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia-2 (CMML-2) - Mayo Clinic

    Current use or use within 14 days prior to randomization of systemic steroid therapy (> 10 mg/day prednisone or equivalent) or any immunosuppressive therapy.